J&J partner: EU rejecting skin infection drug

February 19, 2010 9:57:54 AM PST
Johnson & Johnson on Friday terminated a partnership to develop a highly touted drug for MRSA and other dangerous skin infections after European regulators rejected it over concerns that testing data isn't reliable.

Load Comments